ProUroCare buys up imaging patents:
This article was originally published in Clinica
Executive Summary
In a bid to broaden its IP portfolio, ProUroCare Medical, a developer of mechanical imaging technology for detecting prostate disease, has bought a range of patents relating to prostate and breast imaging technologies from Profile. Minneapolis, Minnesota-based ProUroCare had originally licensed the patents from Profile to develop its ProUroScan prostate imaging system. By owning the patents outright, ProUroCare can pursue additional potential applications in the field of soft tissue imaging. The deal cost $300,000 - half was paid with $150,000 cash and the half was financed under a secured promissory note.
You may also be interested in...
Day One Springs Into Commercial Action With Ojemda Approval
The company is targeting around 200 centers that treat the vast majority of the few thousand pediatric low-grade glioma patients who are candidates for the RAF-targeting drug.
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.